464 related articles for article (PubMed ID: 29491685)
1. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection.
Chen YC; Li CY; Tsai SJ; Chen YC
World J Gastroenterol; 2018 Feb; 24(8):917-928. PubMed ID: 29491685
[TBL] [Abstract][Full Text] [Related]
2. A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan.
Chen YC; Su YC; Li CY; Wu CP; Lee MS
Kidney Int; 2015 May; 87(5):1030-8. PubMed ID: 25426815
[TBL] [Abstract][Full Text] [Related]
3. 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan.
Chen YC; Su YC; Li CY; Hung SK
BMC Nephrol; 2015 Jul; 16():110. PubMed ID: 26199000
[TBL] [Abstract][Full Text] [Related]
4. Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B.
Lee TY; Hsu YC; Yu SH; Lin JT; Wu MS; Wu CY
Clin Gastroenterol Hepatol; 2018 Jun; 16(6):947-954.e4. PubMed ID: 28951229
[TBL] [Abstract][Full Text] [Related]
5. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus infection as a risk factor for chronic kidney disease.
Fabrizi F; Cerutti R; Ridruejo E
Expert Rev Clin Pharmacol; 2019 Sep; 12(9):867-874. PubMed ID: 31456441
[No Abstract] [Full Text] [Related]
7. Association between nucleos(t)ide analogue therapy for hepatitis B and Sjögren's syndrome: 15-year analysis of the national database of Taiwan.
Tung CH; Li CY; Chen YC; Chen YC
J Viral Hepat; 2021 May; 28(5):809-816. PubMed ID: 33550705
[TBL] [Abstract][Full Text] [Related]
8. Nucleos(t)ide analogues associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: a population-based cohort study.
Wang JP; Kao FY; Wu CY; Hung YP; Chao Y; Chou YJ; Li CP
Cancer; 2015 May; 121(9):1446-55. PubMed ID: 25537961
[TBL] [Abstract][Full Text] [Related]
9. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation.
Lee TY; Lin JT; Zeng YS; Chen YJ; Wu MS; Wu CY
Hepatology; 2016 May; 63(5):1517-27. PubMed ID: 26426978
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of hepatitis B surface antigenaemia in patients with incident end-stage renal disease.
Kim AJ; Lee JH; Ko KP; Jung ES; Choi BH; Ro H; Jung JY; Lee HH; Chung W; Chang JH
Nephrology (Carlton); 2016 Nov; 21(11):968-974. PubMed ID: 26617162
[TBL] [Abstract][Full Text] [Related]
11. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.
Lee JJ; Lin MY; Yang YH; Lu SN; Chen HC; Hwang SJ
Am J Kidney Dis; 2010 Jul; 56(1):23-31. PubMed ID: 20400217
[TBL] [Abstract][Full Text] [Related]
12. Associations between hepatitis B infection and chronic kidney disease: 10-Year results from the U.S. National Inpatient Sample.
Geng XX; Tian Z; Liu Z; Chen XM; Xu KJ
Enferm Infecc Microbiol Clin (Engl Ed); 2021 Jan; 39(1):14-21. PubMed ID: 32334907
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals.
Chen YC; Li CY; Tsai SJ; Chen YC
World J Clin Cases; 2019 Jun; 7(11):1270-1281. PubMed ID: 31236391
[TBL] [Abstract][Full Text] [Related]
15. A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease.
Chen YC; Hwang SJ; Li CY; Wu CP; Lin LC
Medicine (Baltimore); 2015 Aug; 94(32):e1334. PubMed ID: 26266379
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
[TBL] [Abstract][Full Text] [Related]
17. Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection.
Lu K; Chiu KY
Transplant Proc; 2023 Sep; 55(7):1581-1587. PubMed ID: 37380588
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors for the development of liver cancer in patients with hepatitis B-related liver cirrhosis treated with long-term nucleos(t)ide analogues].
Zang WW; Su MH; Ling XZ; Wang RM; Cao BC; Wu YL; Deng DL; Wei HL; Liang XS; Jiang JN
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):679-685. PubMed ID: 32911907
[No Abstract] [Full Text] [Related]
19. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
[TBL] [Abstract][Full Text] [Related]
20. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
